| Name | OATD-02 |
|---|
| Description | OATD-02 is an orally active, competitive, reversible, noncovalent dual inhibitor of Arginase1 and 2. OATD-02 is a slow offset inhibitor, blocking intracellular arginases with IC50s of 20 nM (hARG1), 39 nM (hARG2), 39 nM (mARG1), and 28 nM (rARG1), respectively. OATD-02 abolishes tumor immunosuppression induced by both arginases. OATD-02 can be used for melanoma study[1]. |
|---|---|
| Related Catalog | |
| Target |
20 nM (hARG1), 39 nM (hARG2), 39 nM (mARG1), 28 nM (rARG1) |
| References |
| Molecular Formula | C12H25BN2O4 |
|---|---|
| Molecular Weight | 272.15 |